Evidence map›Paper›PMID 35429729›Full record

ReviewCurrent opinion in cell biology2022

New directions for the clathrin adaptor AP-1 in cell biology and human disease.

Mara C Duncan

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Rethinking the Yeast Endomembrane System.Sub-cellular biochemistry · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mara C DuncanDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: mcduncan@umich.edu.
University of Michigan · US

Funding

Mechanism of apicosome-driven lumen formation during human and mouse embryogenesisR01HD102496 · NICHD · MEDICAL COLLEGE OF WISCONSIN · PI TANIGUCHI, KENICHIRO · 2020 to 2024
$1.9M
Regulatory mechanisms of clathrin dependant traffic at the TGN and endosomesR01GM092741 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, MARA C · 2011 to 2015
$1.4M
Characterizing new proteins that determine AP-1 recruitment and distributionR01GM129255 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DUNCAN, MARA C · 2019 to 2022
$1.2M
NICHD NIH HHS R01 HD102496NIGMS NIH HHS R01 GM092741NIGMS NIH HHS R01 GM129255
6 · The paper itself

Abstract

The clathrin adaptor protein complex-1 (AP-1) is a central player in cell physiology and human health. It is best known for its role in linking clathrin to its cargo at the trans-Golgi network and endosomes. It participates in traffic important for the correct function of a large number of organelles, including the trans-Golgi network, endosomes, lysosomes, lysosome-related organelles, and plasma membrane. Although it was one of the first clathrin adaptors identified, new discoveries about cargo and pathways that depend on AP-1 continue to emerge. This review summarizes new research into AP-1 that further illuminates its roles in the traffic of plasma membrane proteins, in maintaining TGN content, and in human disease.

Indexed as

Adaptor Proteins, Vesicular TransportTranscription Factor AP-1Adaptor Protein Complex 1ClathrinEndosomesHumansProtein Transporttrans-Golgi NetworkAdaptor Protein Complex 1Adaptor Proteins, Vesicular TransportClathrinTranscription Factor AP-1

Identifiers

PMID35429729
PMCPMC9187608
OpenAlexW4223994468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.